Life Sciences Archives

Navigating Evolving Risks in the Biotech Industry

The biotech industry thrives on forward thinking and innovative technology—but faces plenty of risks nonetheless. Here’s an industry-wide look.

Read Article

January 26 • Directors & Officers

7 Crucial Cost & Drivers of D&O Insurance

Now more than ever, companies must safeguard their directors and officers — but how? Here’s an inside look at what drives D&O insurance prices.

Read Article

July 21 • Risk Management

Biotech Companies: How Your Pipeline Influences Investors

Biotech companies establish pipelines to land the FDA’s approval for novel drugs eventually — but the process helps to secure funding, too. Here’s how.

Read Article

June 16 • Culture

The Most Promising US Cities for Biotech Startups

From coast to coast, the biotech industry is booming. Here’s a look at the cities helping this space to thrive and why biotech startups flock there.

Read Article

May 19 • Risk Management

FDA Phase 3 Approval: What Insurance Do I Need?

Update: We’ve released a new whitepaper examining the Biotech industry. We dive into the insurance landscape, funding, legal climate, and how to approach risk management for companies in this sector. You can download the report here! Most life sciences professionals understand the FDA drug-approval process. Or, at least, you are aware of how painstaking it is to

Read Article